Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer
Clinical trial NCT03409198 · COMPLETED
Trial details
- NCT number
- NCT03409198
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-21
- Primary completion
- 2022-05-11
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.